PHK
RARX

Point72 Hong Kong’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Point72 Hong Kong’s Portfolio RARX Stock Details RARX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-63
Closed -$1K – 1580
2019
Q3 		$1K Sell
63
-247
-80% -$7.32K ﹤0.01% 946
2019
Q2 		$9K Buy
310
+232
+297% +$5.31K ﹤0.01% 869
2019
Q1 		$2K Buy
78
+29
+59% +$623 ﹤0.01% 920
2018
Q4 		$1K Buy
+49
New +$769 ﹤0.01% 846
2018
Q2 		– Sell
-3,927
Closed -$21K – 1317
2018
Q1 		$21K Buy
3,927
+3,617
+1,167% +$25.9K 0.01% 616
2017
Q4 		$3K Buy
+310
New +$3.81K ﹤0.01% 675

Other funds holding RARX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Hong Kong's RARX Position: Q4 2019 in Review

Point72 Hong Kong sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q4 2019, closing a stake of 63 shares — an estimated $1K sold.

Point72 Hong Kong first reported a position in RARX in Q4 2017 and held it in 6 quarters. The position peaked at $21K in Q1 2018. 146 funds tracked by Wall St. Rank hold RARX as of Q4 2019.

  • Point72 Hong Kong reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Point72 Hong Kong sold 63 Ra Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $1K.
  • Point72 Hong Kong first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 6 quarters.
  • Point72 Hong Kong's Ra Pharmaceuticals, Inc. Common Stock position peaked at $21K in Q1 2018.
  • 146 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Point72 Hong Kong's 13F filing for Q4 2019, filed 14 Feb 2020.